46 results
8-K
EX-1.1
INSM
Insmed Incorporated
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
.
Delaware
Insmed Gene Therapy LLC
Delaware
Insmed Limited
England and Wales
Insmed Holdings Limited
Ireland
Insmed Innovation UK Limited
England
8-K
EX-99.1
INSM
Insmed Incorporated
9 May 24
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
7:05am
Licensing and Access Pathway (ILAP) passport application, granting Innovation Passport designation for brensocatib in the treatment of NCFBE in patients … aged 12 years and older. The ILAP and the Innovation Passport are intended to accelerate time to market, facilitating patient access for important
8-K
EX-99.2
gh8jioy hi0u3fyje
8 May 23
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, “The
7:45am
8-K
EX-99.1
a14y nhawkd5r8
4 May 23
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
4r9y6md
1 Oct 20
Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day
12:00am
8-K
EX-99.2
nckhfq0ct l3gx1ou44v
1 Oct 20
Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day
12:00am
424B5
34ax9pcrmf1jpe1yxe4d
5 May 20
Prospectus supplement for primary offering
5:29pm
424B5
27isb pjen2o0td
22 Jan 18
Prospectus supplement for primary offering
12:00am